Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
157.70
+3.13 (2.02%)
At close: May 13, 2025, 4:00 PM
157.01
-0.69 (-0.44%)
Pre-market: May 14, 2025, 8:46 AM EDT
Tenet Healthcare Market Cap
Tenet Healthcare has a market cap or net worth of $14.65 billion as of May 14, 2025. Its market cap has increased by 50.23% in one year.
Market Cap
14.65B
Enterprise Value
24.82B
1-Year Change
50.23%
Ranking
Category
Stock Price
$157.70
Market Cap Chart
Since December 1, 1998, Tenet Healthcare's market cap has increased from $9.27B to $14.65B, an increase of 58.01%. That is a compound annual growth rate of 1.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 12, 2025 | 14.36B | 19.60% |
Dec 31, 2024 | 12.00B | 56.42% |
Dec 29, 2023 | 7.67B | 45.48% |
Dec 30, 2022 | 5.28B | -39.72% |
Dec 31, 2021 | 8.75B | 107.70% |
Dec 31, 2020 | 4.21B | 6.64% |
Dec 31, 2019 | 3.95B | 124.90% |
Dec 31, 2018 | 1.76B | 14.81% |
Dec 29, 2017 | 1.53B | 3.49% |
Dec 30, 2016 | 1.48B | -51.04% |
Dec 31, 2015 | 3.02B | -39.36% |
Dec 31, 2014 | 4.98B | 19.15% |
Dec 31, 2013 | 4.18B | 20.89% |
Dec 31, 2012 | 3.46B | 55.16% |
Dec 30, 2011 | 2.23B | -31.40% |
Dec 31, 2010 | 3.25B | 25.25% |
Dec 31, 2009 | 2.59B | 372.63% |
Dec 31, 2008 | 548.70M | -77.22% |
Dec 31, 2007 | 2.41B | -26.69% |
Dec 29, 2006 | 3.29B | -8.64% |
Dec 30, 2005 | 3.60B | -29.83% |
Dec 31, 2004 | 5.12B | -31.31% |
Dec 31, 2003 | 7.46B | -6.73% |
Dec 31, 2002 | 8.00B | -58.15% |
Dec 31, 2001 | 19.11B | 35.64% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 677.71B |
Johnson & Johnson | 371.81B |
UnitedHealth Group | 344.01B |
AbbVie | 338.14B |
Novo Nordisk | 292.03B |
Abbott Laboratories | 230.51B |
Novartis AG | 213.30B |
AstraZeneca | 210.42B |